首页> 外文期刊>Neuropsychopharmacology >A Systemically Administered Neurotensin Agonist Blocks Disruption of Prepulse Inhibition Produced by a Serotonin-2A Agonist
【24h】

A Systemically Administered Neurotensin Agonist Blocks Disruption of Prepulse Inhibition Produced by a Serotonin-2A Agonist

机译:系统管理的神经降压素激动剂阻滞由5-羟色胺2A激动剂产生的前脉冲抑制作用。

获取原文
获取外文期刊封面目录资料

摘要

Prepulse inhibition (PPI) of the startle reflex can be disrupted by drugs that act as agonists at the serotonin (5-HT) 2A receptor, such as DOI, and this effect is blocked by drugs that inhibit 5-HT2A transmission. We tested the effects of systemic administration of PD149163, a neurotensin agonist, on DOI-induced disruption of PPI in Sprague–Dawley rats. PD149163 completely and dose dependently blocked the PPI deficits produced by DOI. These findings suggest that, in addition to their established ability to inhibit dopamine transmission, neurotensin agonists may also inhibit 5-HT2A transmission, a pharmacological feature associated with atypical antipsychotic drugs.
机译:充当5-羟色胺(5-HT)2A受体激动剂的药物(如DOI)可破坏惊吓反射的前脉冲抑制(PPI),而这种抑制作用可被抑制5-HT2A传播的药物所阻断。我们测试了神经降压素激动剂PD149163全身给药对DOI诱导的Sprague-Dawley大鼠PPI破坏的影响。 PD149163完全且剂量依赖性地阻断了DOI产生的PPI缺陷。这些发现表明,除了已确立的抑制多巴胺传播的能力外,神经降压素激动剂还可能抑制5-HT2A传播,这是与非典型抗精神病药有关的药理学特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号